USS to distribute Imagyn scope:
This article was originally published in Clinica
Imagyn Medical is to manufacture its 2 mm high-resolution endoscopes under the US Surgical label. As part of an agreement between the two companies, the scope will be added to USS' Minisite line of laparoscopic products marketed worldwide. Some 80% smaller than conventional laparoscopes, the 2 mm scope will compete in a market which Imagyn estimates has a potential value of $150 million. Founded in 1989, privately-held Imagyn Medical produces minimally invasive devices for use in gynaecological surgery.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.